Stockreport

Nymox Announces New Peer Review Publication of Prostate Cancer Fexapotide Clinical Trial Results in World Journal of Urology [Canadian Business Journal (Canada)]

Nymox Pharmaceutical Corporation  (NYMX) 
US:NASDAQ Investor Relations: nymox.com/default.action?itemid=3
PDF HASBROUCK HEIGHTS, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce that a new peer review report was publis [Read more]